In an effort to discover new bioactive anti-tumor lead compounds, a specific tyrosine phosphatase CDC25B and an Erb family receptor EGFR were selected as drug screening targets. This work led to the investigation of the soft coral-derived fungus Talaromyces verruculosus and identification of two new oligophenalenone dimers, verruculosins A-B (1-2), along with three known analogues, bacillisporin F (3), duclauxin (4), and xenoclauxin (5). Compound 1 was the first structure of the oligophenalenone dimer possessing a unique octacyclic skeleton. The detailed structures and absolute configurations of the new compounds were elucidated on the basis of spectroscopic data, X-ray crystallography, optical rotation, Electronic Circular Dichroism (ECD) analysis, and nuclear magnetic resonance (NMR) calculations. Among which, compounds 1, 3, and 5 exhibited modest inhibitory activity against CDC25B with IC 50 values of 0.38 ± 0.03, 0.40 ± 0.02, and 0.26 ± 0.06 µM, respectively.
Structure Elucidation of the New Compounds
Verruculosin A (1) was obtained as a yellowish crystal. The high-resolution electrospray ionization-mass spectrometry (HR-ESI-MS) data recorded at m/z 605.1668 along with the analysis of the NMR data established the molecular formula of 1 as C 32 H 28 O 12 , indicating 19 degrees of unsaturation (DOU). The 13 C and distortionless enhancement by polarization transfer (DEPT) NMR spectroscopic data (Table 1) exhibited the presence of 32 carbons, including five methyls, two methylenes, six methines, and 19 quaternary carbons. The heteronuclear multiple bond correlation (HMBC) correlations from H 2 -1 to C-3 (δ C 168.0) and C-3 b (δ C 143.5) proved the presence of a lactone ring F as shown (Figures 1 and 2) . Additionally, a six-membered ring E was elucidated by the 1 H-1 H homonuclear chemical shift correlation spectroscopy (COSY) relationship H-9 (δ H 5.17) with H-8 (δ H 4.16), and the HMBC correlations ( Figure 2 ) from H-9 to C-7 (δ C 190.9), C-8 (δ C 67.9), and C-3 b, from H-8 to C-7 , C-6 a (δ C 121.1), and C-9 a (δ C 51.4). Observation of the correlations from H-5 (δ H 6.63) to C-3 a (δ C 104.3) and C-6 a (δ C 121.1) from H-10 (δ H 2.06) to C-5 , C-6 a, and C-6 (δ C 151.8) established a benzene ring D, which was fused to rings F and E via C-3 a, C-3 b, and C-6 a. Comparison of the abovementioned data with those of the duclauxin family [7] indicated that compound 1 was probably a dimer possessing two tricyclic moieties. Thus, the presence of another tricyclic moiety was further confirmed by the key HMBC correlations ( Figure 2 ). Finally, the two tricyclic moieties were hinged by a five-membered ring G, which was strongly supported based on the key HMBC correlations ( Figure 2 ) from H-8 , H-9 to C-7, from H 2 -1 , H-9 , H-8 to C-8 (δ C 56.9), from H-8 to C-3 b (δ C 143.5) and C-9 a. The established heptacyclic ring system (rings A-G), accounting for 17 of 19 DOU, and the remaining carbonyl group (δ C 169.6) implied that one more ring should be present in the molecule. The deduction was supported by the 1 H-1 H COSY correlation between H 2 -11 and H-1 as well as the HMBC correlations from H 3 -13 (δ H 1.74) to C-12 (δ C 99.9), C-11 (δ C 36.3), and C-1 (δ C 69.1), from H 2 -11 (δ H α 2.46, β 1.63) to C-12 and C-9a. Thus, the basic planar structure of 1 was determined. Since compound 1 was a novel oligophenalenone dimer possessing an octacyclic ring system, X-ray diffraction was necessary to confirm its structure and absolute configuration. To our delight, a high-quality crystal of 1 ( Figure 3 ) was successfully obtained from CHCl 3 and X-ray crystallographic analysis was carried out by applying the anomalous dispersion of Cu Kα diffraction. Therefore, the absolute configurations of 1 were unambiguously assigned as 1R, 7S, 8S, 8 S, 9 S, 9 aR, and 12S by the refinement of the Flack parameter [0.13 (11) ]. The structure of 1 was thus elucidated as shown ( Figure 1) . system, X-ray diffraction was necessary to confirm its structure and absolute configuration. To our delight, a high-quality crystal of 1 ( Figure 3 ) was successfully obtained from CHCl3 and Xray crystallographic analysis was carried out by applying the anomalous dispersion of Cu Kα diffraction. Therefore, the absolute configurations of 1 were unambiguously assigned as 1R, 7S, 8S, 8′S, 9′S, 9′aR, and 12S by the refinement of the Flack parameter [0.13 (11) ]. The structure of 1 was thus elucidated as shown ( Figure 1 ). our delight, a high-quality crystal of 1 ( Figure 3 ) was successfully obtained from CHCl3 and Xray crystallographic analysis was carried out by applying the anomalous dispersion of Cu Kα diffraction. Therefore, the absolute configurations of 1 were unambiguously assigned as 1R, 7S, 8S, 8′S, 9′S, 9′aR, and 12S by the refinement of the Flack parameter [0.13 (11) ]. The structure of 1 was thus elucidated as shown ( Figure 1 ). ray crystallographic analysis was carried out by applying the anomalous dispersion of Cu Kα diffraction. Therefore, the absolute configurations of 1 were unambiguously assigned as 1R, 7S, 8S, 8′S, 9′S, 9′aR, and 12S by the refinement of the Flack parameter [0.13 (11) ]. The structure of 1 was thus elucidated as shown ( Figure 1 ). Verruculosin B (2) was obtained as a yellowish oil. Its molecular formula C 32 H 28 O 13 was determined by HR-ESI-MS, with three carbon atoms, six proton atoms, and two oxygen atoms more than duclauxin (4). The 1 H and 13 C NMR data of 2 were similar to those of duclauxin (4) ( Table 1 ), suggesting the same carbon skeleton for both compounds. The major difference was found by the presence of an additional moiety in 2, which was assigned to a methoxycarbonylmethyl moiety based on the key HMBC correlations ( Figure 2 ) from H 3 -13 (δ H 3.65), H 2 -11 (δ H α 2.70, β 2.93) to the ester carbonyl C-12 (δ C 173.0). Moreover, the linkage of the methoxycarbonyl-methyl moiety to C-1 (δ C 70.6) was confirmed by the HMBC correlations ( Figure 2 ) from H 2 -11 to C-9a (δ C 103.9) and from H-1 (δ H 5.56) to C-12, along with the 1 H-1 H COSY relationship between H 2 -11 and H-1. Additionally, Mar. Drugs 2019, 17, 516 5 of 10 the resonance at δ C 191.0 for a ketone group at the C-9 position in 4 was not present in the 13 C NMR spectrum of 2 (Table 1) . Rather, the signal indicative of a nonprotonated olefinic carbon at δ C 150.9 (C-9) was observed in the 13 C NMR spectrum of 2 (Table 1 ). These data indicated the replacement of the ketone group (C-9) in 4 by a hydroxylated olefinic carbon in 2, which was consistent with the difference in the molecular formula.
The relative configurations of 2 were assigned the same as those of 1 on the basis of the nuclear overhauser effect spectroscopy (NOESY) correlations ( Figure 4) . Meanwhile, the ECD spectra ( Figure 5 ) and optical rotation of 2 matched those of 1 and 4 [14, 15] . Therefore, we concluded that compound 2 possessed the same absolute configuration as verruculosin A (1) and duclauxin (4) [10] . In order to complement the above deduction for the configuration of C-1, we utilized NMR calculations [10, 16, 17] . (Table 1 ), suggesting the same carbon skeleton for both compounds. The major difference was found by the presence of an additional moiety in 2, which was assigned to a methoxycarbonylmethyl moiety based on the key HMBC correlations ( Figure 2 ) from H3-13 (δH 3.65), H2-11 (δH α 2.70, β 2.93) to the ester carbonyl C-12 (δC 173.0). Moreover, the linkage of the methoxycarbonyl-methyl moiety to C-1 (δC 70.6) was confirmed by the HMBC correlations ( Figure 2 ) from H2-11 to C-9a (δC 103.9) and from H-1 (δH 5.56) to C-12, along with the 1 H-1 H COSY relationship between H2-11 and H-1. Additionally, the resonance at δC 191.0 for a ketone group at the C-9 position in 4 was not present in the 13 C NMR spectrum of 2 (Table 1) . Rather, the signal indicative of a nonprotonated olefinic carbon at δC 150.9 (C-9) was observed in the 13 C NMR spectrum of 2 (Table 1) . These data indicated the replacement of the ketone group (C-9) in 4 by a hydroxylated olefinic carbon in 2, which was consistent with the difference in the molecular formula.
The relative configurations of 2 were assigned the same as those of 1 on the basis of the nuclear overhauser effect spectroscopy (NOESY) correlations (Figure 4) . Meanwhile, the ECD spectra ( Figure 5 ) and optical rotation of 2 matched those of 1 and 4 [14, 15] . Therefore, we concluded that compound 2 possessed the same absolute configuration as verruculosin A (1) and duclauxin (4) [10] . In order to complement the above deduction for the configuration of C- found by the presence of an additional moiety in 2, which was assigned to a methoxycarbonylmethyl moiety based on the key HMBC correlations (Figure 2 ) from H3-13 (δH 3.65), H2-11 (δH α 2.70, β 2.93) to the ester carbonyl C-12 (δC 173.0). Moreover, the linkage of the methoxycarbonyl-methyl moiety to C-1 (δC 70.6) was confirmed by the HMBC correlations ( Figure 2 ) from H2-11 to C-9a (δC 103.9) and from H-1 (δH 5.56) to C-12, along with the 1 H-1 H COSY relationship between H2-11 and H-1. Additionally, the resonance at δC 191.0 for a ketone group at the C-9 position in 4 was not present in the 13 C NMR spectrum of 2 (Table 1) . Rather, the signal indicative of a nonprotonated olefinic carbon at δC 150.9 (C-9) was observed in the 13 C NMR spectrum of 2 (Table 1) . These data indicated the replacement of the ketone group (C-9) in 4 by a hydroxylated olefinic carbon in 2, which was consistent with the difference in the molecular formula.
The relative configurations of 2 were assigned the same as those of 1 on the basis of the nuclear overhauser effect spectroscopy (NOESY) correlations (Figure 4) . Meanwhile, the ECD spectra ( Figure 5 ) and optical rotation of 2 matched those of 1 and 4 [14, 15] . Therefore, we concluded that compound 2 possessed the same absolute configuration as verruculosin A (1) and duclauxin (4) [10] . In order to complement the above deduction for the configuration of C- The first step in making stereochemistry assignment was to do a conformational search, geometry optimization, and calculate NMR shielding constant, 1 H, and 13 C shifts for each candidate structure as described in computational methods (Supporting Information, S1). The next step was to match the experimental shifts with those of the calculated results, and values of mean absolute error (MAE), corrected mean absolute error (CMAE), maximum error (MaxErr), corrected maximum error (CMaxErr), the correlation coefficient, and DP4 probability were then calculated as described in the computational method (Supporting Information, S1). The results ( Table 2) showed that it was not obvious regarding the correlation coefficient (r 2 > 0.99 in all cases), while the MAE, CMAE, MaxErr, and CMaxErr parameters of diastereomer 1R were better than those of diastereomer 1S. Moreover, the DP4 probability of diastereomer 1R, combining 1 H and 13 C values, was assigned as 100%, while those of the diastereomer Mar. Drugs 2019, 17, 516 6 of 10 1S was assigned as 0%, suggesting Rconfiguration for C-1. Therefore, the absolute configuration of 2 was assigned as depicted (1R, 7S, 8S, 8 S, 9 S, 9 aR). ). The structure of 3 was elucidated from NMR data, which was in accordance with that reported [8] . The absolute configurations of 3 were determined and confirmed by the single crystal X-ray diffraction analysis ( Figure 6 ) for the first time. The final refinement of the Cu Kα data resulted in a 0.05 (14) Flack parameter, allowing an unambiguous assignment of the absolute configurations as 1S, 8 R, 9 aS, and 9 S. were then calculated as described in the computational method (Supporting Information, S1). The results (Table 2) showed that it was not obvious regarding the correlation coefficient (r 2 ˃ 0.99 in all cases), while the MAE, CMAE, MaxErr, and CMaxErr parameters of diastereomer 1R were better than those of diastereomer 1S. Moreover, the DP4 probability of diastereomer 1R, combining 1 H and 13 C values, was assigned as 100%, while those of the diastereomer 1S was assigned as 0%, suggesting R-configuration for C-1. Therefore, the absolute configuration of 2 was assigned as depicted (1R, 7S, 8S, 8′S, 9′S, 9′aR). Bacillisporin F (3) was isolated as a yellowish crystal (from MeOH and CH2Cl2) with the molecular formula C29H22O11 as determined by HR-ESI-MS ([M − H] -at m/z 545.1094). The structure of 3 was elucidated from NMR data, which was in accordance with that reported [8] . The absolute configurations of 3 were determined and confirmed by the single crystal X-ray diffraction analysis ( Figure 6 ) for the first time. The final refinement of the Cu Kα data resulted in a 0.05 (14) Flack parameter, allowing an unambiguous assignment of the absolute configurations as 1S, 8′R, 9′aS, and 9′S. In addition to compounds 1-3, two known compounds, including duclauxin (4) [14, 15] and xenoclauxin (5) [7] (Figure 1) , were also isolated and elucidated by NMR and MS data comparison with the above literature.
Biological Activities of the Isolated Compounds
The crude extracts and isolated compounds were assayed for their inhibitory effects on EGFR [18] and CDC25B [12] . Despite their structural similarity, compounds 1-5 displayed remarkable differences in their activity spectra ( Table 3 ). The EGFR tyrosine kinase assay showed that compounds 1-5 showed a weak inhibitory effect on EGFR. Besides, compounds 1, 3, and 5 displayed potent CDC25B inhibitory activities with IC 50 values of 0.38 ± 0.03, 0.40 ± 0.02, and 0.26 ± 0.06 µM, respectively (Na 3 VO 4 , positive control, IC 50 0.52 ± 0.02 µM). The results indicated that oligophenalenone dimers might be used for screening as the new natural CDC25B inhibitor candidates. 
Experimental Section

General
UV spectra were measured in methanol on a TU-1810 spectrophotometer (Beijing Purkinje General Instrument Company Limited, Beijing, China). X-ray crystallographic data were measured on a D/MAX-RC X-ray diffractometer (Rigaku Corporation, Krakow, Poland). Optical rotations were recorded in CHCl 3 using a Rudolph Autopol III polarimeter (Rudolph Research Analytical, Hackettstown, NJ, USA) at 25 • C. Melting points were measured on a BUCHI M-560 melting point apparatus. NMR Spectra were recorded on a Bruker AVANCE III-600 MHz spectrometer (Bruker Corporation, Fällanden, Switzerland), and tetramethylsilane (TMS) was used as the internal standard. ECD spectra were measured on a JASCO J-810 circular dichroism spectrometer (JASCO Corporation, Tokyo, Japan) using MeOH as a solvent at 25 • C. HR-ESI-MS spectra were performed on a Xevo G 2 -QTOF spectrometer (Waters Corporation, Milford, MA, USA). Precoated silica gel plates (Qingdao Haiyang Chemical Group Co., Qingdao, China; GF 254 ) were used for thin layer chromatography. Silica gel (Qingdao Haiyang Chemical Group Co., Qingdao, China; 100-200 mesh, 200-300 mesh), RP-18 reverse-phase silica gel (Silicycle, Quebec, Canada; 50 µm), and Sephadex LH-20 (GE Healthcare Bio-Sciences Corporation, Piscataway, NJ, USA) were used for column chromatography.
Fungal Material
The fungus was isolated from the soft coral Goniopora sp. collected from Sanya, Hainan island, South China Sea, China. The fungus was identified as Talaromyces verruculosus by analysis of the internal transcribed spacer (ITS) region sequence of its rDNA, as described previously [19] . The sequence data obtained from the fungus was submitted to GeneBank with accession number KU 057944. A voucher strain was deposited in the Technical Innovation Center for Utilization of Marine Biological Resources, Third Institute of Oceanography, Ministry of Natural Resources.
Fermentation
The fungus Talaromyces verruculosus was inoculated into 500 mL Erlenmeyer flasks containing 300 mL liquid medium (glucose 1%, maltose 2%, corn steep liquor 0.1%, yeast extract 0.3%, monosodium glutamate 1%, mannitol 2%, KH 2 PO 4 0.05%, MgSO 4 ·7H 2 O 0.03%, seawater, pH 7.5). Static fermentation was then incubated at room temperature for 35 days.
Extraction and Isolation
The fermented whole broth (21 L) was filtrated to separate the supernatant from the mycelia. The supernatant was stirred three times with ethyl acetate (EtOAc) and was then concentrated under reduced pressure to obtain an EtOAc crude extract. The air-dried mycelia were immersed in acetone-H 2 O (4:1) with ultrasonic processor for 30 min before evaporating to afford an aqueous solution, which was extracted three times with EtOAc to yield a further EtOAc crude extract. Since both EtOAc extracts showed similar high performance liquid chromatography (HPLC) and thin layer chromatography (TLC) profiles, they were combined to afford an extract (27 g) for further purification. The extract was separated into seven fractions (Fr.1-Fr.7) on a silica gel column chromatography (CC) using a step gradient elution with MeOH-CH 2 Cl 2 (0-100% 
EGFR Activity Assay
The EGFR tyrosine kinase inhibitory activity was tested using enzyme-linked immunosorbent assay (ELISA). The compounds were dissolved in dimethyl sulfoxide (DMSO) buffer solution and were then distributed to a 96-well plate pre-coated with poly(Glu, Tyr) 4:1 as a substrate. Each well was treated with 50 µL of 10 µM ATP solution diluted with reaction buffer and the reaction was started by the addition of EGFR tyrosine kinase. After 60 min of incubation at 37 • C, the plate was washed three times with phosphate buffered saline containing 0.1% Tween 20 (PBST). Next, antiphosphotyrosine (PY99) antibody 100 µL was added. After incubation for 30 min at 37 • C, the plate was washed three times and goat anti-mouse IgG horseradish peroxidase was added. The plate was reincubated at 37 • C for 30 min and washed as before. Lastly, 100 µL of color development solution was added and the plate was incubated at room temperature until color emerged. The reaction was terminated by adding 50 µL of 2 M H 2 SO 4 , and the absorbance was measured on the Molecular Devices SpectraMax 190 microplatereader at 490 nm [20] . The known EGFR inhibitor, afatibib, was utilized as a positive control, and 0.1% (v/v) DMSO was used as a negative control.
CDC25B Activity Assay
The enzymatic activity of the CDC25B was determined at 30 • C by monitoring the dephosphorylation of 3-O-methylfluorescein phosphate (OMFP), which was used as a substrate for the CDC25B and can be monitored at a 535 nm emission wavelength and 485 nm excitation wavelength in the EnVisionmultilabel plate reader [21] . The assay was measured in a 100 µL mixture system containing 50 mM Tris-HCl, pH 8.0, 50 mM NaCl, 10 µM OMFP, 100 nM CDC25B, 1 mM dithiothreitol (DTT), 1 mM ethylene diamine tetraacetic acid (EDTA), 1% glycerin, and 2 mg/L compound. The initial rate of the dephosphorylation was determined using the early linear region of the enzymatic reaction kinetic curve. DMSO and Na 3 VO 4 were used as negative and positive controls, respectively.
